Next Article in Journal
Is the Hedgehog Pathway Involved in the Pathophysiology of Schizophrenia? A Systematic Review of Current Evidence of Neural Molecular Correlates and Perspectives on Drug Development
Next Article in Special Issue
Free Salivary Amino Acid Profile in Breast Cancer: Clinicopathological and Molecular Biological Features
Previous Article in Journal
Single-Cell Sequencing Technology in Ruminant Livestock: Challenges and Opportunities
Previous Article in Special Issue
Adverse Skeletal Muscle Adaptations in Individuals Born Preterm—A Comprehensive Review
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Molecular Biological Research on the Pathogenic Mechanism of Retinoblastoma

Department of Ophthalmology, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China
*
Authors to whom correspondence should be addressed.
These authors contributed equally to this work.
Curr. Issues Mol. Biol. 2024, 46(6), 5307-5321; https://doi.org/10.3390/cimb46060317
Submission received: 28 March 2024 / Revised: 14 May 2024 / Accepted: 20 May 2024 / Published: 27 May 2024
(This article belongs to the Collection Molecular Mechanisms in Human Diseases)

Abstract

Retinoblastoma (RB) is the most common intraocular malignant tumor in children, primarily attributed to the bi-allelic loss of the RB1 gene in the developing retina. Despite significant progress in understanding the basic pathogenesis of RB, comprehensively unravelling the intricate network of genetics and epigenetics underlying RB tumorigenesis remains a major challenge. Conventional clinical treatment options are limited, and despite the continuous identification of genetic loci associated with cancer pathogenesis, the development of targeted therapies lags behind. This review focuses on the reported genomic and epigenomic alterations in retinoblastoma, summarizing potential therapeutic targets for RB and providing insights for research into targeted therapies.
Keywords: retinoblastoma; molecular biological; RB1; epigenetics retinoblastoma; molecular biological; RB1; epigenetics

Share and Cite

MDPI and ACS Style

Ma, X.; Li, X.; Sun, Q.; Luan, F.; Feng, J. Molecular Biological Research on the Pathogenic Mechanism of Retinoblastoma. Curr. Issues Mol. Biol. 2024, 46, 5307-5321. https://doi.org/10.3390/cimb46060317

AMA Style

Ma X, Li X, Sun Q, Luan F, Feng J. Molecular Biological Research on the Pathogenic Mechanism of Retinoblastoma. Current Issues in Molecular Biology. 2024; 46(6):5307-5321. https://doi.org/10.3390/cimb46060317

Chicago/Turabian Style

Ma, Xiangyi, Xinyu Li, Qi Sun, Fuxiao Luan, and Jing Feng. 2024. "Molecular Biological Research on the Pathogenic Mechanism of Retinoblastoma" Current Issues in Molecular Biology 46, no. 6: 5307-5321. https://doi.org/10.3390/cimb46060317

APA Style

Ma, X., Li, X., Sun, Q., Luan, F., & Feng, J. (2024). Molecular Biological Research on the Pathogenic Mechanism of Retinoblastoma. Current Issues in Molecular Biology, 46(6), 5307-5321. https://doi.org/10.3390/cimb46060317

Article Metrics

Back to TopTop